Prestige BioPharma Limited (KRX:950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,400
-120 (-0.96%)
At close: Oct 24, 2025

Prestige BioPharma Market Cap

Prestige BioPharma has a market cap or net worth of 149.04 billion as of October 24, 2025. Its market cap has decreased by -14.36% in one year.

Market Cap
149.04B
Enterprise Value
216.81B
Revenue
14.33B
Ranking
n/a
PE Ratio
33.50
Stock Price
12,400.00

Market Cap Chart

Since May 28, 2021, Prestige BioPharma's market cap has decreased from 360.58B to 149.04B, a decrease of -58.67%. That is a compound annual growth rate of -18.15%.

History

DateMarket Cap% Change
Oct 24, 2025149.04B-17.94%
Dec 30, 2024181.61B59.39%
Dec 28, 2023113.94B29.33%
Dec 29, 202288.10B-64.84%
Dec 30, 2021250.60B-30.50%
May 28, 2021360.58B-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Samsung Biologics83.84T
Celltrion38.09T
ALTEOGEN23.85T
Yuhan8.54T
SK Biopharmaceuticals8.34T
Peptron6.00T
HLB Co., Ltd.5.98T
PharmaResearch5.69T
Market Cap Rankings